• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Thrombocytopenia as an initial manifestation of COVID-19; case series and literature review.

作者信息

Ahmed Maria Zahid, Khakwani Muhammad, Venkatadasari Indrani, Horgan Claire, Giles Hannah, Jobanputra Shailesh, Lokare Anand, Ewing Joanne, Paneesha Shankara, Murthy Vidhya

机构信息

Department of Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

出版信息

Br J Haematol. 2020 Jun;189(6):1057-1058. doi: 10.1111/bjh.16769. Epub 2020 Jun 2.

DOI:10.1111/bjh.16769
PMID:32369609
Abstract
摘要

相似文献

1
Thrombocytopenia as an initial manifestation of COVID-19; case series and literature review.血小板减少作为新型冠状病毒肺炎的初始表现；病例系列及文献综述
Br J Haematol. 2020 Jun;189(6):1057-1058. doi: 10.1111/bjh.16769. Epub 2020 Jun 2.
2
Mechanisms involved in the development of thrombocytopenia in patients with COVID-19.与 COVID-19 患者血小板减少症发展相关的机制。
Thromb Res. 2020 Sep;193:110-115. doi: 10.1016/j.thromres.2020.06.008. Epub 2020 Jun 5.
3
Atypical Spontaneous Hematomas in a Patient with Severe Coronavirus Disease 2019 (COVID-19).一名重症2019冠状病毒病（COVID-19）患者的非典型自发性血肿
Semin Thromb Hemost. 2020 Oct;46(7):856-858. doi: 10.1055/s-0040-1715092. Epub 2020 Sep 2.
4
Incidence of heparin-induced thrombocytopenia in patients with 2019 coronavirus disease.2019冠状病毒病患者肝素诱导的血小板减少症的发病率
Med Clin (Barc). 2020 Nov 13;155(9):409-410. doi: 10.1016/j.medcli.2020.05.041. Epub 2020 Jul 28.
5
Hemostatic laboratory derangements in COVID-19 with a focus on platelet count.新型冠状病毒肺炎患者止血实验室检查异常特征分析，重点关注血小板计数。
Platelets. 2020 Aug 17;31(6):740-745. doi: 10.1080/09537104.2020.1768523. Epub 2020 May 26.
6
Thrombocytopenia is independently associated with poor outcome in patients hospitalized for COVID-19.血小板减少症与因新冠肺炎住院患者的不良预后独立相关。
Br J Haematol. 2020 Sep;190(5):e276-e279. doi: 10.1111/bjh.16950. Epub 2020 Aug 31.
7
Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）感染时免疫性血小板减少症的复发
Ann Hematol. 2020 Aug;99(8):1951-1952. doi: 10.1007/s00277-020-04130-2. Epub 2020 Jun 11.
8
Platelets in Coronavirus Disease 2019.2019冠状病毒病中的血小板
Semin Thromb Hemost. 2020 Oct;46(7):823-825. doi: 10.1055/s-0040-1710006. Epub 2020 Apr 30.
9
Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis.血小板减少症与严重的 2019 年冠状病毒病（COVID-19）感染相关：一项荟萃分析。
Clin Chim Acta. 2020 Jul;506:145-148. doi: 10.1016/j.cca.2020.03.022. Epub 2020 Mar 13.
10
Unexpected Severe Thrombocytopenia in the COVID-19 Positive Parturient.新冠病毒检测呈阳性的产妇出现意外严重血小板减少症。
Anesth Analg. 2020 Aug;131(2):e116-e117. doi: 10.1213/ANE.0000000000004948.

引用本文的文献

1
Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection.分子模拟、免疫系统亢进和 SARS-CoV-2 是 COVID-19 感染后引发自身免疫性疾病三角的三个前提条件。
Int Immunopharmacol. 2022 Nov;112:109183. doi: 10.1016/j.intimp.2022.109183. Epub 2022 Aug 22.
2
Efficacy and safety of nafamostat mesilate anticoagulation in blood purification treatment of critically ill patients: a systematic review and meta-analysis.甲磺酸萘莫司他抗凝在危重症患者血液净化治疗中的疗效和安全性：系统评价和荟萃分析。
Ren Fail. 2022 Dec;44(1):1263-1279. doi: 10.1080/0886022X.2022.2105233.
3
Post-Operative Bleeding Complications in a Periodontitis Patient Testing Positive for COVID-19.
一名COVID-19检测呈阳性的牙周炎患者的术后出血并发症
Dent J (Basel). 2022 Jun 14;10(6):110. doi: 10.3390/dj10060110.
4
The Development of Immune Thrombocytopenia Due to COVID-19 Presenting as Menorrhagia.新型冠状病毒肺炎所致免疫性血小板减少症表现为月经过多的进展情况
Cureus. 2022 Apr 15;14(4):e24160. doi: 10.7759/cureus.24160. eCollection 2022 Apr.
5
Idiopathic thrombocytopenic purpura as a hematologic manifestation of COVID-19 infection: A case report.特发性血小板减少性紫癜作为新型冠状病毒肺炎感染的血液学表现：一例报告
Respir Med Case Rep. 2021;34:101534. doi: 10.1016/j.rmcr.2021.101534. Epub 2021 Oct 21.
6
Repurposing FIB-4 index as a predictor of mortality in patients with hematological malignancies and COVID-19.将 FIB-4 指数重新用作血液系统恶性肿瘤合并 COVID-19 患者死亡率的预测指标。
PLoS One. 2021 Sep 23;16(9):e0257775. doi: 10.1371/journal.pone.0257775. eCollection 2021.
7
Autoimmune complications of COVID-19.新型冠状病毒肺炎的自身免疫并发症
J Med Virol. 2022 Jan;94(1):54-62. doi: 10.1002/jmv.27292. Epub 2021 Aug 31.
8
Intravenous immunoglobulin as adjuvant therapy for COVID-19: A case report and literature review.静脉注射免疫球蛋白作为COVID-19的辅助治疗：一例病例报告及文献综述
SAGE Open Med Case Rep. 2021 Jun 30;9:2050313X211029699. doi: 10.1177/2050313X211029699. eCollection 2021.
9
Extrapulmonary onset manifestations of COVID-19.COVID-19 的肺外发病表现。
Clinics (Sao Paulo). 2021 Jul 5;76:e2900. doi: 10.6061/clinics/2021/e2900. eCollection 2021.
10
Evans syndrome and immune thrombocytopenia in two patients with COVID-19.两名新冠肺炎患者并发伊文氏综合征和免疫性血小板减少症。
J Med Virol. 2021 May;93(5):2642-2644. doi: 10.1002/jmv.26906. Epub 2021 Mar 9.